Tubot, Cristina C.
HRN: 23-46-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/03/2023
08/10/2023
IV
1.5
Q6
Breast CA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes